WallStSmart

Align Technology Inc (ALGN)vsBecton Dickinson and Company (BDX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Becton Dickinson and Company generates 443% more annual revenue ($21.92B vs $4.03B). ALGN leads profitability with a 10.2% profit margin vs 8.0%. ALGN appears more attractively valued with a PEG of 1.06. ALGN earns a higher WallStSmart Score of 68/100 (B-).

ALGN

Strong Buy

68

out of 100

Grade: B-

Growth: 6.7Profit: 6.5Value: 9.3Quality: 5.3
Piotroski: 3/9Altman Z: 2.59

BDX

Buy

61

out of 100

Grade: C+

Growth: 5.3Profit: 5.5Value: 10.0Quality: 6.5
Piotroski: 6/9Altman Z: 1.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALGNUndervalued (+25.3%)

Margin of Safety

+25.3%

Fair Value

$264.42

Current Price

$180.27

$84.15 discount

UndervaluedFair: $264.42Overvalued
BDXUndervalued (+36.9%)

Margin of Safety

+36.9%

Fair Value

$286.42

Current Price

$158.27

$128.15 discount

UndervaluedFair: $286.42Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALGN2 strengths · Avg: 8.0/10
Operating MarginProfitability
22.4%8/10

Strong operational efficiency at 22.4%

EPS GrowthGrowth
35.6%8/10

Earnings expanding 35.6% YoY

BDX3 strengths · Avg: 8.3/10
Market CapQuality
$56.49B9/10

Large-cap with strong market position

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

EPS GrowthGrowth
28.6%8/10

Earnings expanding 28.6% YoY

Areas to Watch

ALGN2 concerns · Avg: 3.5/10
P/E RatioValuation
31.7x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

BDX4 concerns · Avg: 3.3/10
P/E RatioValuation
25.5x4/10

Moderate valuation

Revenue GrowthGrowth
1.6%4/10

1.6% revenue growth

Return on EquityProfitability
7.0%3/10

ROE of 7.0% — below average capital efficiency

Altman Z-ScoreHealth
1.492/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ALGN

The strongest argument for ALGN centers on Operating Margin, EPS Growth. PEG of 1.06 suggests the stock is reasonably priced for its growth.

Bull Case : BDX

The strongest argument for BDX centers on Market Cap, Price/Book, EPS Growth. PEG of 1.16 suggests the stock is reasonably priced for its growth.

Bear Case : ALGN

The primary concerns for ALGN are P/E Ratio, Piotroski F-Score.

Bear Case : BDX

The primary concerns for BDX are P/E Ratio, Revenue Growth, Return on Equity.

Key Dynamics to Monitor

ALGN carries more volatility with a beta of 1.82 — expect wider price swings.

ALGN is growing revenue faster at 5.3% — sustainability is the question.

BDX generates stronger free cash flow (549M), providing more financial flexibility.

Monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ALGN scores higher overall (68/100 vs 61/100). BDX offers better value entry with a 36.9% margin of safety. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Align Technology Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Align Technology is a manufacturer of 3D digital scanners and the Invisalign clear aligners used in orthodontics. It is headquartered in San Jose, California.

Becton Dickinson and Company

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.

Visit Website →

Want to dig deeper into these stocks?